GEM Aromatics Limited
NSE: GEMAROMA · Specialty Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹16 cr vs borrowings ₹150 cr (FY26): borrowings are higher by ₹134 cr.
- Operating profit covered interest -0.1x in the last 12 months.
- Promoter holding rose by 2.39 percentage points in a year, to 57.45% (2026-09-30).
- Net loss in 3 of the last 5 quarters.
- No dividend in the last 1 financial years.
- Price ₹136.63 on 2026-10-26: -45.1% from the 52-week high, +2.7% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 88 | 90 | 79 | 110 | 99 |
| EBITDA | 15 | 3 | 7 | 16 | 3 |
| OPM % | 17.0% | 3.4% | 8.9% | 14.2% | 3.3% |
| Other income | 1 | 1 | -2 | 0 | 0 |
| Net profit | 8 | -3 | -5 | 1 | -8 |
| EPS (₹) | 1.70 | -0.04 | -1.04 | 0.19 | -1.56 |
| Revenue YoY | +12.8% | ||||
| Profit YoY | -198.6% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 366 | 378 |
| EBITDA | 41 | 29 |
| Net profit | 1 | -14 |
| EPS (₹) | 0.28 | -2.45 |
| Dividend / share (₹) | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | -38.4% |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 450 |
| Borrowings | 150 |
| Cash & equivalents | 16 |
| Total assets | 642 |
| Fixed assets | 243 |
| Capital work in progress | 6 |
| Investments | 0 |
| Receivables | 77 |
| Inventory | 234 |
| Payables | 19 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | 30 |
| Cash from investing | -101 |
| Cash from financing | 78 |
| Capex | 95 |
| Free cash flow | -66 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 0.3% |
| ROCE % | 3.2% |
| Debtor days | 76 |
| Inventory days | 309 |
| Payable days | 25 |
| Cash conversion cycle (days) | 360 |
| Working capital days | 195 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 57.45% |
| FIIs | 0.39% |
| DIIs | 4.95% |
| Public (non-institutions) | 37.21% |
| Quarter | Aug 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Promoters % | 55.06% | 55.06% | 55.06% | 57.01% | 57.45% | 57.45% |
| Promoter group | % |
|---|---|
| Parekh Family Trust | 20.29% |
| Vipul Nathalal Parekh | 18.22% |
| Yash Vipul Parekh | 9.55% |
| Kaksha Vipul Parekh | 9.39% |
| Yash Vipul Parekh HUF | 0.00% |
| Vruta Yash Parekh | 0.00% |
| Prisha Yash Parekh | 0.00% |
| Bhavna Sunil Sanghvi | 0.00% |
| Vasudha Kirti Vakharia | 0.00% |
| Lopa Janak Mehta | 0.00% |
| Krishna Lallubhai Chitalia | 0.00% |
| Lallubhai Hargovindas Chitalia | 0.00% |
| Rajesh Lallubhai Chitalia | 0.00% |
| Lallubhai Chitalia HUF | 0.00% |
| Sneh Ajmera | 0.00% |
| Public holders above 1% | % |
|---|---|
| Doterra Enterprises S.a.r.l. | 18.36% |
| Nippon India Equity Opportunities AIF - Scheme 7 | 1.80% |
| Sageone-flagship Growth OE Fund | 1.72% |
57,883 shareholders. Pledged: – of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| GEMAROMA | ₹714 cr | – | 1.6x | -3.2% | -0.2% | 7.7% | – | – |
Documents
- Annual report FY26
- Annual report FY26
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | GEMAROMA |
| BSE code | 544491 |
| ISIN | INE06XZ01023 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.